Finally, a recent study identified the cell cycle regulator CDK1 as a key promoter of early cystogenesis in ADPKD, and crucially demonstrated that genetic ablation of this gene inhibited cell cycle progression and ameliorated kidney disease phenotypes in vivo (Zhang et al., 2021). Here, CDK1 is linked to autosomal dominant polycystic kidney disease.